Trial intelligence / Profile preview

MR4 vs Prograf in De Novo Liver Transplant

NCT00719745Phase 3Completed

Sponsor
Astellas Pharma
Start
Feb 2006
Primary completion
Jun 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of tacrolimus + Wuzhi capsule in Liver transplant rejection, sponsored by Astellas Pharma. Started Feb 2006; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT00719745.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00719745.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call